Mepivacaína Braun

Mepivacaine Hydrochloride, the active ingredient in Mepivacaína Braun, is a local anesthetic presented as a sterile solution for epidural, intramuscular and intravenous use. It provides reversible loss of sensation for surgical and diagnostic procedures in adult patients. GNH USA supplies Mepivacaína Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mepivacaine Hydrochloride is used in clinical settings to achieve local and regional anesthesia through sodium‑channel blockade. - Local anesthesia: produces temporary loss of sensation for minor surgical or dental procedures. - Epidural analgesia: provides pain relief during labor, childbirth, or postoperative recovery. - Intramuscular anesthesia: enables muscle block for diagnostic or therapeutic interventions.

Mepivacaine Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Injection site pain or burning sensation - Mild hypotension or dizziness - Nausea or metallic taste - Transient tremor or muscle twitching - Headache - Light‑headedness

Serious or Rare Side Effects: - Allergic reactions including anaphylaxis - Cardiac arrhythmias or conduction disturbances - Central nervous system toxicity such as seizures - Prolonged or profound nerve block - Methemoglobinemia - Respiratory depression or apnea

When using Mepivacaína Braun, clinicians should observe specific safety measures to minimize risk. - Patient assessment: evaluate cardiovascular and hepatic status before administration. - Dose adjustment: reduce concentration in patients with liver impairment or advanced age. - Contraindications: avoid in individuals with known hypersensitivity to amide‑type local anesthetics. - Monitoring: observe for signs of CNS toxicity, hypotension, or arrhythmia during and after injection. - Drug interactions: review concurrent medications that affect sodium channels or CNS function. - Store at ambient temperature: keep in original container, protect from light and moisture.

Mepivacaine Hydrochloride can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may potentiate cardiotoxicity. - Other local anesthetics: increase risk of systemic toxicity. - Systemic CNS depressants (e.g., barbiturates, benzodiazepines): enhance central effects. - Beta‑adrenergic blockers: may exacerbate hypotensive response. - MAO inhibitors: risk of severe hypertension.

Moderate Interactions (Monitor Closely): - Epinephrine: can prolong block duration and affect cardiovascular response. - Calcium channel blockers: may increase myocardial depression. - Diuretics: potential for altered plasma protein binding. - Lithium: heightened risk of neurotoxicity.